Every patient deserves the best therapy.

Cannovum is a fully licensed pharmaceutical wholesaler, importer and manufacturer of high-quality medical cannabis.

About Cannovum
NEW

Live available inventory

Easily check product availability and price.

New

Pharmacy Workshops

Secure a free, customized workshop now. Online or in your pharmacy.

Customer and product service
Services

Your advantages

Free Shipping

No postage costs for you. Our delivery is free of charge, with no minimum order value.

Free return

You can return all unopened products easily and free of charge. We will refund the full amount.

Free Workshop & Consultation

We're offering you and your team free medical education and free consultation

Values

Patients first

The well-being of patients is our highest priority. We aim to facilitate the development of a regulated cannabis market in Europe to help patients obtain the best possible therapy.

Values

Safety and Quality

Safety and quality are the most important factors for us. Our cannabis is imported from GMP-certified producers, who adhere to the highest standards. Every step of our supply chain from the cultivation to the distribution is regulated and controlled.

Values

Cannabis for Europe

Although the beneficial medical properties of cannabis are increasingly established, developments aimed at leveraging these benefits have been slow in Europe. Cannovum clearly focuses on the European market, pioneering our cannabis revolution.

For pharmacies

Our Onlineshop

Pharmacists can easily register with our online shop to place orders. If you have any questions about our products and the associated service, please contact our trained service staff.

Sign up
Screenshot of Cannovum's Online Shop
Network

Our partners

Partner BPCPartner Hanfverband
News

Latest News

News
November 25, 2021

Cannovum AG decides to enter the recreational cannabis market

Following the coalition agreement, Cannovum AG will enter into the recreational cannabis market. The present offer in the field of medical cannabis will be maintained and further expanded.

News
September 29, 2021

Cannovum AG receives active ingredient license

This is an extension of the wholesale permit and allows the trade of active ingredients. One of the main active ingredients of cannabis is THC, which is considered to have the greatest pharmaceutical potential and therapeutic efficacy.

News
September 8, 2021

Cannovum AG expands Supervisory Board and Medical Advisory Board

Priv. Doz. Dr. med. habil. Philipp Sewerin is the new member of the supervisory board as well as the Medical Advisory Board. Dr. Sewerin is a specialist in internal medicine and rheumatology at the university clinic in Düsseldorf.

For investors

If you would like to invest in Cannovum feel free to check and contact us in our investor relations page.

Investor relations

Cannovum Newsletter

Get the latest information and insights:

check_circle
Successfully subscribed
Something went wrong while submitting the form.
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.